(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -26.68%268.02M | -44.49%125.66M | -22.78%365.56M | 3.75%226.36M | 8.22%473.39M | 8.46%218.18M | 20.81%437.45M | --201.16M | 15.97%362.09M | 15.98%312.24M |
Operating income | -26.68%268.02M | -44.49%125.66M | -22.78%365.56M | 3.75%226.36M | 8.22%473.39M | 8.46%218.18M | 20.81%437.45M | 201.16M | 15.97%362.09M | 15.98%312.24M |
Cost of sales | 32.59%-170.66M | 50.10%-80.11M | 28.33%-253.15M | 0.62%-160.55M | -14.15%-353.21M | -16.45%-161.55M | -22.16%-309.42M | ---138.73M | -11.49%-253.3M | -11.83%-227.19M |
Operating expenses | 32.59%-170.66M | 50.10%-80.11M | 28.33%-253.15M | 0.62%-160.55M | -14.15%-353.21M | -16.45%-161.55M | -22.16%-309.42M | -138.73M | -11.49%-253.3M | -11.83%-227.19M |
Gross profit | -13.38%97.37M | -30.78%45.56M | -6.46%112.41M | 16.22%65.81M | -6.13%120.18M | -9.29%56.63M | 17.67%128.03M | 62.43M | 27.92%108.8M | 28.75%85.05M |
Selling expenses | -367.77%-20.85M | -279.49%-8.4M | 16.05%-4.46M | 19.58%-2.21M | -18.69%-5.31M | -19.59%-2.75M | 7.49%-4.47M | ---2.3M | -17.15%-4.84M | -2.74%-4.13M |
Administrative expenses | 4.76%-33.92M | 6.12%-16.96M | 4.76%-35.62M | 1.13%-18.07M | 10.13%-37.4M | 13.83%-18.28M | 4.28%-41.61M | ---21.21M | -34.19%-43.48M | -43.26%-32.4M |
Research and development expenses | 5.85%-7.89M | -7.80%-4.3M | 4.49%-8.38M | 2.61%-3.99M | -11.79%-8.77M | -22.44%-4.09M | 10.04%-7.85M | ---3.34M | -6.86%-8.72M | -69.58%-8.16M |
Special items of operating profit | -29.56%5.01M | -57.14%3.42M | 111.42%7.11M | 378.00%7.97M | 246.49%3.36M | 204.91%1.67M | -165.61%-2.3M | ---1.59M | 48.91%3.5M | -7.52%2.35M |
Operating profit | -44.12%39.71M | -61.00%19.31M | -1.38%71.07M | 49.26%49.52M | 0.37%72.06M | -2.38%33.17M | 29.92%71.8M | 33.98M | 29.39%55.26M | 14.96%42.71M |
Financing income | 77.55%9.28M | 296.16%4.34M | 1,981.27%5.22M | 4,280.00%1.1M | 33.51%251K | 66.67%25K | 189.23%188K | --15K | 333.33%65K | 0.00%15K |
Financing cost | -16,200.00%-163K | ---- | 95.83%-1K | 93.75%-1K | 67.57%-24K | 66.67%-16K | 69.80%-74K | ---48K | ---245K | ---- |
Earning before tax | -36.01%48.82M | -53.27%23.65M | 5.53%76.29M | 52.51%50.61M | 0.53%72.29M | -2.26%33.18M | 30.56%71.91M | 33.95M | 28.92%55.08M | 14.95%42.73M |
Tax | 16.38%-10.11M | 45.76%-5.39M | 3.86%-12.09M | -46.05%-9.93M | 8.74%-12.57M | 0.18%-6.8M | -17.47%-13.77M | ---6.81M | -31.71%-11.73M | -26.99%-8.9M |
After-tax profit from continuing operations | -39.70%38.72M | -55.10%18.26M | 7.51%64.21M | 54.18%40.68M | 2.72%59.72M | -2.79%26.38M | 34.10%58.14M | 27.14M | 28.18%43.36M | 12.16%33.82M |
Earning after tax | -39.70%38.72M | -55.10%18.26M | 7.51%64.21M | 54.18%40.68M | 2.72%59.72M | -2.79%26.38M | 34.10%58.14M | 27.14M | 28.18%43.36M | 12.16%33.82M |
Profit attributable to shareholders | -39.70%38.72M | -55.10%18.26M | 7.51%64.21M | 54.18%40.68M | 2.72%59.72M | -2.79%26.38M | 34.10%58.14M | 27.14M | 28.18%43.36M | 12.16%33.82M |
Basic earnings per share | -40.00%0.03 | -56.25%0.014 | 6.38%0.05 | 52.38%0.032 | -11.32%0.047 | -25.00%0.021 | 15.22%0.053 | 0.028 | -100.00%0.046 | 12.16%16.91M |
Diluted earnings per share | -40.00%0.03 | -56.25%0.014 | 6.38%0.05 | 52.38%0.032 | -11.32%0.047 | -25.00%0.021 | 15.22%0.053 | 0.028 | -100.00%0.046 | 12.16%16.91M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data